Avalon GloboCare Corp.
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
ALBT | US
Overview
Corporate Details
- ISIN(s):
- US05344R3021 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 4400 ROUTE 9, 7728 FREEHOLD
- Sector:
- Manufacturing
Description
Avalon GloboCare Corp. is a commercial-stage company dedicated to developing and delivering transformative healthcare solutions. The company's activities are centered on two main areas: advancing cell-based immunotherapies and providing precision diagnostics with clinical laboratory services. Its therapeutic development focuses on immune effector cell therapies, including Chimeric Antigen Receptor T-cell (CAR-T) technology. In diagnostics, its core technology platforms include the KetoAir™ breathalyzer, which utilizes nanosensor technology, and the QTY protein design platform, a joint intellectual property with the Massachusetts Institute of Technology (MIT). The company also operates clinical laboratories offering an extensive menu of services, such as general bloodwork, anatomic pathology, urine toxicology, and pharmacogenomics (PGx) testing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Avalon GloboCare Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Avalon GloboCare Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Avalon GloboCare Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||